134 related articles for article (PubMed ID: 25468802)
1. Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinoma.
Okuma Y; Hosomi Y; Takahashi S; Maeda Y; Okamura T; Hishima T
Clin Lung Cancer; 2015 May; 16(3):221-7. PubMed ID: 25468802
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes with chemotherapy for advanced thymic carcinoma.
Okuma Y; Hosomi Y; Takagi Y; Sasaki E; Hishima T; Maeda Y; Shibuya M; Okamura T
Lung Cancer; 2013 Apr; 80(1):75-80. PubMed ID: 23313005
[TBL] [Abstract][Full Text] [Related]
3. The potency of curative-intent treatment for advanced thymic carcinoma.
Okuma Y; Horio H; Hosomi Y; Watanabe K; Maeda Y; Okamura T; Hishima T
Lung Cancer; 2014 May; 84(2):175-81. PubMed ID: 24646831
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and prognosis in advanced thymic carcinoma patients.
Song Z; Yu X; Zhang Y
Clinics (Sao Paulo); 2015 Dec; 70(12):775-80. PubMed ID: 26735216
[TBL] [Abstract][Full Text] [Related]
5. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.
Asao T; Fujiwara Y; Sunami K; Kitahara S; Goto Y; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Ichikawa H; Kohno T; Tsuta K; Watanabe S; Takahashi K; Ohe Y
Lung Cancer; 2016 Mar; 93():77-81. PubMed ID: 26898618
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy for thymic carcinoma].
Okuma Y
Gan To Kagaku Ryoho; 2012 May; 39(5):702-7. PubMed ID: 22584319
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases.
Zhao Y; Zhao H; Hu D; Fan L; Shi J; Fang W
Ann Thorac Surg; 2013 Sep; 96(3):1019-24. PubMed ID: 23866799
[TBL] [Abstract][Full Text] [Related]
9. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel for platinum-refractory advanced thymic carcinoma.
Watanabe N; Umemura S; Niho S; Kirita K; Matsumoto S; Yoh K; Ohmatsu H; Goto K
Jpn J Clin Oncol; 2015 Jul; 45(7):665-9. PubMed ID: 25840444
[TBL] [Abstract][Full Text] [Related]
11. Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter Study.
Modh A; Rimner A; Allen PK; Greenfield B; Marom EM; Rice D; Huang J; Rosenzweig KE; Komaki R; Gomez DR
Am J Clin Oncol; 2016 Apr; 39(2):120-5. PubMed ID: 24390276
[TBL] [Abstract][Full Text] [Related]
12. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
Agatsuma T; Koizumi T; Kanda S; Ito M; Urushihata K; Yamamoto H; Hanaoka M; Kubo K
J Thorac Oncol; 2011 Dec; 6(12):2130-4. PubMed ID: 21892103
[TBL] [Abstract][Full Text] [Related]
14. Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinoma.
Hirai F; Seto T; Inamasu E; Toyokawa G; Yoshida T; Nosaki K; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Anticancer Res; 2014 Oct; 34(10):5743-7. PubMed ID: 25275083
[TBL] [Abstract][Full Text] [Related]
15. Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.
Liang Y; Padda SK; Riess JW; West RB; Neal JW; Wakelee HA
Lung Cancer; 2015 Jan; 87(1):34-8. PubMed ID: 25443273
[TBL] [Abstract][Full Text] [Related]
16. The role of chemotherapy in advanced thymoma.
Schmitt J; Loehrer PJ
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S357-60. PubMed ID: 20859133
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma.
Igawa S; Murakami H; Takahashi T; Nakamura Y; Tsuya A; Naito T; Kaira K; Ono A; Shukuya T; Tamiya A; Endo M; Yamamoto N
Lung Cancer; 2010 Feb; 67(2):194-7. PubMed ID: 19409644
[TBL] [Abstract][Full Text] [Related]
18. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT).
Stachowicz-Stencel T; Orbach D; Brecht I; Schneider D; Bien E; Synakiewicz A; Rod J; Ferrari A; Cecchetto G; Bisogno G
Eur J Cancer; 2015 Nov; 51(16):2444-52. PubMed ID: 26259494
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after surgical resection of thymic carcinoma: A study from a single tertiary referral centre.
Song Z; Zhang Y
Eur J Surg Oncol; 2014 Nov; 40(11):1523-7. PubMed ID: 24953416
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer.
Furugen M; Sekine I; Tsuta K; Horinouchi H; Nokihara H; Yamamoto N; Kubota K; Tamura T
Jpn J Clin Oncol; 2011 Aug; 41(8):1013-6. PubMed ID: 21742653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
